Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06641414
Title Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Acronym GLORA-4
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Ascentage Pharma Group Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
MD Anderson Cancer Center Houston Texas 77054 United States Details
Peking University People's Hospital Beijing Beijing 100033 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field